Abiopharma

News list

Director Lang James Paul 🟢 acquired 420.5K shares (2 derivative) of BIOVIE INC. (BIVI) at $1.31 Transaction Date: Jan 05, 2026 | Filing ID: 000017

Full text

News bot Jan. 9, 2026, 10:05 p.m.
🔍 Lang James Paul (Director)

Company: BIOVIE INC. (BIVI)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 420,500
Detailed Transactions and Holdings:
- Acquired 90,000 shares of Stock Option (right to buy) at $1.31 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2031-01-05 | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 330,500 shares of Stock Option (right to buy) at $1.31 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2031-01-05 | equity_swap_involved: 0 | shares_owned_after: 330,500.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
- F2: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.